about semaglutide injections Ozempic® (semaglutide) GLP-1 RA for Type 2 Diabetes Semgo Semaglutide Injection | Cell

Research Summary: The following information is provided for research context only.

Contact your healthcare provider within 24 hours if you experience: Persistent vomiting preventing adequate fluid intake Signs of dehydration (dark urine, dizziness, dry mouth) Severe or worsening abdominal pain Recurrent hypoglycemia Depression or suicidal thoughts (rare but reported with Wegovy) Persistent resting heart rate increases with symptoms like dizziness or chest pain Pregnancy while taking semaglutide (stop Wegovy immediately) Maintain open communication with your healthcare team throughout treatment

10.1016/j.neuropharm.2019.05.018 56 LauA.VilleneuveN

Daneshkhah, A